{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:43:51Z","timestamp":1791859431612,"version":"4.3.4"},"reference-count":68,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Accumulating evidence from mainly uncontrolled clinical studies with various types of ablation catheters have shown that renal denervation (RDN) can be applied safely and is effective in lowering blood pressure (BP) in patients with treatment-resistant hypertension. Sustained BP lowering has been documented up to 3 years. Furthermore, RDN has been associated with regression of target organ damage, such as left ventricular hypertrophy, arterial stiffness, and others. Several studies indicate potential benefit in other common clinical conditions associated with increased sympathetic tone including chronic kidney disease and heart failure. However, the recently published Symplicity HTN-3 study, the largest and most rigorously designed sham-controlled clinical trial, while confirming the safety of the procedure, failed to demonstrate a BP lowering effect beyond that of a sham procedure in patients with resistant hypertension. Efforts to unravel the reasons for the discrepant results from Symplicity HTN-3 have focused on a range of potential confounders including anatomical and procedural aspects. Indeed, data from post-hoc analyses indicate that sufficient RDN may not have been achieved in the majority of patients in Symplicity HTN-3. Furthermore, recent evidence from human postmortem and functional animal studies revealed new insights into the anatomical distribution of renal nerves and their accessibility by intravascular approaches. Initial results from recent clinical trials integrating these important findings indeed seem to confirm that RDN remains a viable option for the treatment of hypertension. Thorough further investigations will be key to determine the true potential of RDN in clinical conditions characterized by increased sympathetic drive.<\/jats:p>","DOI":"10.1093\/ajh\/hpx033","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T03:56:05Z","timestamp":1487130965000},"page":"847-856","source":"Crossref","is-referenced-by-count":18,"title":["Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension"],"prefix":"10.1093","volume":"30","author":[{"given":"Markus P","family":"Schlaich","sequence":"first","affiliation":[{"name":"Dobney Hypertension Centre, School of Medicine and Pharmacology\u2014Royal Perth Hospital Unit, University of Western Australia 1 ;"},{"name":"Cardiology Department, Royal Perth Hospital 2 , Perth, Western Australia , Australia ;"},{"name":"Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute 3 , Melbourne, Victoria , Australia ."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,3,1]]},"reference":[{"key":"2022111817461091600_CIT0001","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1001\/jama.1953.03690160001001","article-title":"Splanchnicectomy for essential hypertension; results in 1,266 cases","volume":"152","author":"Smithwick","year":"1953","journal-title":"J Am Med Assoc"},{"key":"2022111817461091600_CIT0002","doi-asserted-by":"crossref","first-page":"R633","DOI":"10.1152\/ajpregu.00258.2005","article-title":"Physiology in perspective: The Wisdom of the Body. Neural control of the kidney","volume":"289","author":"DiBona","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2022111817461091600_CIT0003","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1161\/01.HYP.14.2.177","article-title":"Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings","volume":"14","author":"Anderson","year":"1989","journal-title":"Hypertension"},{"key":"2022111817461091600_CIT0004","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjhyper.2003.10.010","article-title":"Relationship between central sympathetic activity and stages of human hypertension","volume":"17","author":"Smith","year":"2004","journal-title":"Am J Hypertens"},{"key":"2022111817461091600_CIT0005","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.CIR.0000081775.72651.B6","article-title":"Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy","volume":"108","author":"Schlaich","year":"2003","journal-title":"Circulation"},{"key":"2022111817461091600_CIT0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/01.HYP.0000103160.35395.9E","article-title":"Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation","volume":"43","author":"Schlaich","year":"2004","journal-title":"Hypertension"},{"key":"2022111817461091600_CIT0007","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.HYP.3.2.149","article-title":"Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients","volume":"3","author":"Esler","year":"1981","journal-title":"Hypertension"},{"key":"2022111817461091600_CIT0008","first-page":"E21","article-title":"Measurement of total and organ-specific norepinephrine kinetics in humans","volume":"247","author":"Esler","year":"1984","journal-title":"Am J Physiol"},{"key":"2022111817461091600_CIT0009","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study","volume":"373","author":"Krum","year":"2009","journal-title":"Lancet"},{"key":"2022111817461091600_CIT0010","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMc0904179","article-title":"Renal sympathetic-nerve ablation for uncontrolled hypertension","volume":"361","author":"Schlaich","year":"2009","journal-title":"N Engl J Med"},{"key":"2022111817461091600_CIT0011","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/eurheartj\/ehq457","article-title":"Novel procedure- and device-based strategies in the management of systemic hypertension","volume":"32","author":"Krum","year":"2011","journal-title":"Eur Heart J"},{"key":"2022111817461091600_CIT0012","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11906-009-0078-6","article-title":"Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension","volume":"12","author":"Schlaich","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"2022111817461091600_CIT0013","doi-asserted-by":"crossref","first-page":"E503","DOI":"10.1210\/jc.2010-2204","article-title":"The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components","volume":"96","author":"Straznicky","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2022111817461091600_CIT0014","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/db08-1595","article-title":"Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese metabolic syndrome subjects","volume":"58","author":"Straznicky","year":"2009","journal-title":"Diabetes"},{"key":"2022111817461091600_CIT0015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2213-8587(14)70033-6","article-title":"Metabolic syndrome: a sympathetic disease?","volume":"3","author":"Schlaich","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2022111817461091600_CIT0016","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.2337\/db12-0138","article-title":"Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects","volume":"61","author":"Straznicky","year":"2012","journal-title":"Diabetes"},{"key":"2022111817461091600_CIT0017","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-201X.2003.01091.x","article-title":"Sympathetic nerve activity in obstructive sleep apnoea","volume":"177","author":"Narkiewicz","year":"2003","journal-title":"Acta Physiol Scand"},{"key":"2022111817461091600_CIT0018","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1097\/01.ASN.0000098687.01005.A5","article-title":"Sympathetic nerve activity is inappropriately increased in chronic renal disease","volume":"14","author":"Klein","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"2022111817461091600_CIT0019","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1681\/ASN.V12112427","article-title":"Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension","volume":"12","author":"Klein","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"2022111817461091600_CIT0020","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJM199904293401704","article-title":"Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure","volume":"340","author":"Ligtenberg","year":"1999","journal-title":"N Engl J Med"},{"key":"2022111817461091600_CIT0021","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1681\/ASN.2008040402","article-title":"Sympathetic activation in chronic renal failure","volume":"20","author":"Schlaich","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2022111817461091600_CIT0022","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","article-title":"Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study","volume":"123","author":"Mahfoud","year":"2011","journal-title":"Circulation"},{"key":"2022111817461091600_CIT0023","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/HYPERTENSIONAHA.111.173799","article-title":"Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea","volume":"58","author":"Witkowski","year":"2011","journal-title":"Hypertension"},{"key":"2022111817461091600_CIT0024","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2011111062","article-title":"Renal denervation in moderate to severe CKD","volume":"23","author":"Hering","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"2022111817461091600_CIT0025","article-title":"Effect of renal denervation on kidney function in patients with chronic kidney disease","author":"Hering","year":"2017","journal-title":"Int J Cardiol"},{"key":"2022111817461091600_CIT0026","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/HJH.0000000000000556","article-title":"Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension","volume":"33","author":"Ott","year":"2015","journal-title":"J Hypertens"},{"key":"2022111817461091600_CIT0027","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/hc1102.105261","article-title":"Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease","volume":"105","author":"Zoccali","year":"2002","journal-title":"Circulation"},{"key":"2022111817461091600_CIT0028","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/eurheartj\/ehi184","article-title":"Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure","volume":"26","author":"Petersson","year":"2005","journal-title":"Eur Heart J"},{"key":"2022111817461091600_CIT0029","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(13)62192-3","article-title":"Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study","volume":"383","author":"Krum","year":"2014","journal-title":"Lancet"},{"key":"2022111817461091600_CIT0030","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"key":"2022111817461091600_CIT0031","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1161\/CIRCULATIONAHA.112.130880","article-title":"Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial","volume":"126","author":"Esler","year":"2012","journal-title":"Circulation"},{"key":"2022111817461091600_CIT0032","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"key":"2022111817461091600_CIT0033","doi-asserted-by":"crossref","first-page":"F1267","DOI":"10.1152\/ajprenal.00058.2016","article-title":"What we need to know about renal nerve ablation for treatment of hypertension and other states of sympathetic overactivity","volume":"311","author":"Schlaich","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"2022111817461091600_CIT0034","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jash.2014.06.001","article-title":"Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings","volume":"8","author":"Esler","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"2022111817461091600_CIT0035","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/eurheartj\/ehu091","article-title":"Renal denervation for hypertension: observations and predictions of a founder","volume":"35","author":"Esler","year":"2014","journal-title":"Eur Heart J"},{"key":"2022111817461091600_CIT0036","doi-asserted-by":"crossref","first-page":"285fs18","DOI":"10.1126\/scitranslmed.aaa5457","article-title":"Renal denervation: not as easy as it looks","volume":"7","author":"Esler","year":"2015","journal-title":"Sci Transl Med"},{"key":"2022111817461091600_CIT0037","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/eurheartj\/ehu441","article-title":"Predictors of blood pressure response in the SYMPLICITY HTN-3 trial","volume":"36","author":"Kandzari","year":"2015","journal-title":"Eur Heart J"},{"key":"2022111817461091600_CIT0038","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(14)61942-5","article-title":"Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial","volume":"385","author":"Azizi","year":"2015","journal-title":"Lancet"},{"key":"2022111817461091600_CIT0039","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/HYPERTENSIONAHA.116.08448","article-title":"Twenty-four-hour blood pressure monitoring to predict and assess impact of renal denervation: the DENERHTN study (renal denervation for hypertension)","volume":"69","author":"Gosse","year":"2017","journal-title":"Hypertension"},{"key":"2022111817461091600_CIT0040","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/HYPERTENSIONAHA.115.05283","article-title":"Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension","volume":"65","author":"Desch","year":"2015","journal-title":"Hypertension"},{"key":"2022111817461091600_CIT0041","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/HJH.0000000000000977","article-title":"Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial","volume":"34","author":"Mathiassen","year":"2016","journal-title":"J Hypertens"},{"key":"2022111817461091600_CIT0042","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/HYPERTENSIONAHA.115.06526","article-title":"Role of adding spironolactone and renal denervation in true resistant hypertension: one-year outcomes of randomized PRAGUE-15 study","volume":"67","author":"Rosa","year":"2016","journal-title":"Hypertension"},{"key":"2022111817461091600_CIT0043","doi-asserted-by":"crossref","DOI":"10.1097\/HJH.0000000000001257","article-title":"Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study","author":"Rosa","year":"2017","journal-title":"J Hypertens"},{"key":"2022111817461091600_CIT0044","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/HYPERTENSIONAHA.114.05010","article-title":"First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension","volume":"65","author":"B\u00f6hm","year":"2015","journal-title":"Hypertension"},{"key":"2022111817461091600_CIT0045","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1097\/HJH.0000000000001085","article-title":"Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry","volume":"34","author":"B\u00f6hm","year":"2016","journal-title":"J Hypertens"},{"key":"2022111817461091600_CIT0046","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/jch.12820","article-title":"A short history of automated office blood pressure\u201415 years to SPRINT","volume":"18","author":"Myers","year":"2016","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2022111817461091600_CIT0047","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/HJH.0b013e32834de621","article-title":"Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement","volume":"30","author":"Head","year":"2012","journal-title":"J Hypertens"},{"key":"2022111817461091600_CIT0048","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/08037051.2013.812549","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension","volume":"22","author":"Mancia","year":"2013","journal-title":"Blood Press"},{"key":"2022111817461091600_CIT0049","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ajh\/2.8.650","article-title":"Importance of left ventricular mass as a predictor of cardiovascular morbidity in hypertension","volume":"2","author":"Devereux","year":"1989","journal-title":"Am J Hypertens"},{"key":"2022111817461091600_CIT0050","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","article-title":"Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial","volume":"110","author":"Devereux","year":"2004","journal-title":"Circulation"},{"key":"2022111817461091600_CIT0051","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension","volume":"59","author":"Brandt","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2022111817461091600_CIT0052","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/eurheartj\/ehu093","article-title":"Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial","volume":"35","author":"Mahfoud","year":"2014","journal-title":"Eur Heart J"},{"key":"2022111817461091600_CIT0053","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1161\/HYPERTENSIONAHA.112.191965","article-title":"Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea","volume":"60","author":"Linz","year":"2012","journal-title":"Hypertension"},{"key":"2022111817461091600_CIT0054","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jacc.2012.05.036","article-title":"A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension","volume":"60","author":"Pokushalov","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2022111817461091600_CIT0055","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.hrthm.2015.01.039","article-title":"Reverse cardiac remodeling after renal denervation: atrial electrophysiologic and structural changes associated with blood pressure lowering","volume":"12","author":"McLellan","year":"2015","journal-title":"Heart Rhythm"},{"key":"2022111817461091600_CIT0056","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/HYPERTENSIONAHA.112.193870","article-title":"Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension","volume":"60","author":"Mahfoud","year":"2012","journal-title":"Hypertension"},{"key":"2022111817461091600_CIT0057","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ijcard.2014.03.017","article-title":"Improvement of albuminuria after renal denervation","volume":"173","author":"Ott","year":"2014","journal-title":"Int J Cardiol"},{"key":"2022111817461091600_CIT0058","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/eurheartj\/eht200","article-title":"Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension","volume":"34","author":"Kiuchi","year":"2013","journal-title":"Eur Heart J"},{"key":"2022111817461091600_CIT0059","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1097\/HJH.0b013e3283622e58","article-title":"Renal nerve ablation reduces augmentation index in patients with resistant hypertension","volume":"31","author":"Hering","year":"2013","journal-title":"J Hypertens"},{"key":"2022111817461091600_CIT0060","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.113.03098","article-title":"Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension","volume":"64","author":"Hering","year":"2014","journal-title":"Hypertension"},{"key":"2022111817461091600_CIT0061","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2215\/CJN.08500812","article-title":"Vascular and renal hemodynamic changes after renal denervation","volume":"8","author":"Ott","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"2022111817461091600_CIT0062","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.03.059","article-title":"Anatomic assessment of sympathetic peri-arterial renal nerves in man","volume":"64","author":"Sakakura","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2022111817461091600_CIT0063","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1172\/JCI100695","article-title":"The effect of renal denervation on patients suffering from nephritis","volume":"14","author":"Page","year":"1935","journal-title":"J Clin Invest"},{"key":"2022111817461091600_CIT0064","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.jacc.2015.08.018","article-title":"Impact of lesion placement on efficacy and safety of catheter-based radiofrequency renal denervation","volume":"66","author":"Mahfoud","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022111817461091600_CIT0065","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/ajh\/hpu258","article-title":"Catheter-based radiofrequency renal denervation: location effects on renal norepinephrine","volume":"28","author":"Henegar","year":"2015","journal-title":"Am J Hypertens"},{"key":"2022111817461091600_CIT0066","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/ajh\/hpu048","article-title":"Catheter-based radiorefrequency renal denervation lowers blood pressure in obese hypertensive dogs","volume":"27","author":"Henegar","year":"2014","journal-title":"Am J Hypertens"},{"key":"2022111817461091600_CIT0067","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ijcard.2015.09.015","article-title":"Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension","volume":"202","author":"Hering","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022111817461091600_CIT0068","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/HJH.0000000000001160","article-title":"Denervation of the distal renal arterial branches vs. conventional main renal artery treatment: a randomized controlled trial for treatment of resistant hypertension","volume":"35","author":"Pekarskiy","year":"2017","journal-title":"J Hypertens"}],"container-title":["American Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/30\/9\/847\/47133132\/ajh_30_9_847.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajh\/article-pdf\/30\/9\/847\/47133132\/ajh_30_9_847.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T12:47:00Z","timestamp":1668775620000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajh\/article\/30\/9\/847\/3058759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,1]]},"references-count":68,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,3,1]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajh\/hpx033","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727454653.793571591","asserted-by":"object"}]},"ISSN":["0895-7061","1941-7225"],"issn-type":[{"value":"0895-7061","type":"print"},{"value":"1941-7225","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9]]},"published":{"date-parts":[[2017,3,1]]}}}